AR Green

546 total citations
11 papers, 434 citations indexed

About

AR Green is a scholar working on Pharmacology, Clinical Psychology and Toxicology. According to data from OpenAlex, AR Green has authored 11 papers receiving a total of 434 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Clinical Psychology and 3 papers in Toxicology. Recurrent topics in AR Green's work include Forensic Toxicology and Drug Analysis (3 papers), Psychedelics and Drug Studies (3 papers) and Acute Myeloid Leukemia Research (2 papers). AR Green is often cited by papers focused on Forensic Toxicology and Drug Analysis (3 papers), Psychedelics and Drug Studies (3 papers) and Acute Myeloid Leukemia Research (2 papers). AR Green collaborates with scholars based in United Kingdom, Australia and Italy. AR Green's co-authors include James R. Docherty, Elisabeth P. Nacheva, R. Douglas Sammons, Philip J. Cowen, Sheila Fraser, C. Glenn Begley, HF Woods, E Nacheva, G. Curzon and David Bloxham and has published in prestigious journals such as Blood, Cancer Research and British Journal of Pharmacology.

In The Last Decade

AR Green

11 papers receiving 410 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
AR Green United Kingdom 7 150 121 78 70 68 11 434
B. Krebs France 11 142 0.9× 198 1.6× 39 0.5× 153 2.2× 21 0.3× 30 609
Eszter Dömötör Hungary 8 130 0.9× 81 0.7× 33 0.4× 12 0.2× 40 0.6× 11 371
Martine Germain France 11 31 0.2× 109 0.9× 76 1.0× 100 1.4× 129 1.9× 12 331
Sylviane Ragot France 11 18 0.1× 92 0.8× 68 0.9× 32 0.5× 20 0.3× 18 358
Alisha A. McBride United States 7 9 0.1× 113 0.9× 28 0.4× 28 0.4× 55 0.8× 11 366
Ioana Inta Germany 12 13 0.1× 256 2.1× 17 0.2× 16 0.2× 83 1.2× 17 645
Sonya N. Meeker United States 9 23 0.2× 116 1.0× 87 1.1× 165 2.4× 109 1.6× 9 721
C.A. Jennings United Kingdom 12 94 0.6× 115 1.0× 29 0.4× 18 0.3× 131 1.9× 14 375
Marcello Polesel Switzerland 11 15 0.1× 111 0.9× 13 0.2× 23 0.3× 36 0.5× 12 442
M. Couturier France 7 28 0.2× 117 1.0× 21 0.3× 5 0.1× 64 0.9× 13 306

Countries citing papers authored by AR Green

Since Specialization
Citations

This map shows the geographic impact of AR Green's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by AR Green with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites AR Green more than expected).

Fields of papers citing papers by AR Green

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by AR Green. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by AR Green. The network helps show where AR Green may publish in the future.

Co-authorship network of co-authors of AR Green

This figure shows the co-authorship network connecting the top 25 collaborators of AR Green. A scholar is included among the top collaborators of AR Green based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with AR Green. AR Green is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Green, AR, et al.. (2012). Ecstasy cannot be assumed to be 3,4‐methylenedioxyamphetamine (MDMA). British Journal of Pharmacology. 166(5). 1521–1522. 4 indexed citations
2.
Green, AR, et al.. (2011). P4-09-11: Kinesin Family Member 2C (KIF2C) Is a New Surrogate Prognostic Marker in Breast Cancer (BC).. Cancer Research. 71(24_Supplement). P4–9. 4 indexed citations
3.
Docherty, James R. & AR Green. (2010). The role of monoamines in the changes in body temperature induced by 3,4‐methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives. British Journal of Pharmacology. 160(5). 1029–1044. 68 indexed citations
4.
Green, AR, et al.. (2009). Effect of acute brain tyrosine depletion on MDMA-induced changes in brain 5-HT. Journal of Psychopharmacology. 24(2). 267–274. 2 indexed citations
5.
Bockamp, Ernesto, Fiona McLaughlin, Adele Murrell, et al.. (1995). Lineage-restricted regulation of the murine SCL/TAL-1 promoter. Blood. 86(4). 1502–1514. 66 indexed citations
6.
Tanigawa, Tetsuya, Lorraine Robb, AR Green, & C. Glenn Begley. (1994). Constitutive expression of the putative transcription factor SCL associated with proviral insertion in the myeloid leukemic cell line WEHI-3BD-.. PubMed. 5(6). 557–61. 13 indexed citations
7.
Nacheva, Elisabeth P., et al.. (1994). Molecular analysis of chromosome 20q deletions associated with myeloproliferative disorders and myelodysplastic syndromes. Blood. 84(9). 3086–3094. 84 indexed citations
8.
Nacheva, E, et al.. (1994). Deletion of chromosome 20q in myelodysplasia can occur in a multipotent precursor of both myeloid cells and B cells. Blood. 83(10). 2809–2816. 71 indexed citations
9.
Cowen, Philip J., Sheila Fraser, R. Douglas Sammons, & AR Green. (1983). Atenolol reduces plasma melatonin concentration in man.. British Journal of Clinical Pharmacology. 15(5). 579–581. 74 indexed citations
10.
Green, AR, JK Aronson, G. Curzon, & HF Woods. (1980). Metabolism of an oral tryptophan load. II: Effect of pretreatment with the putative tryptophan pyrrolase inhibitors nicotinamide or allopurinol.. British Journal of Clinical Pharmacology. 10(6). 611–615. 5 indexed citations
11.
Green, AR, JK Aronson, G. Curzon, & HF Woods. (1980). Metabolism of an oral tryptophan load. I: Effects of dose and pretreatment with tryptophan.. British Journal of Clinical Pharmacology. 10(6). 603–610. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026